Currently, two key injectable drugs are leading this revolution: semaglutide (marketed as Wegovy) and tirzepatide (sold as Mounjaro). Semaglutide is also the active ingredient in Ozempic, a medication used to treat type 2 diabetes. Both are administered via weekly, self-injectable pens into the upper arm, thigh, or stomach, typically starting at a low dose and gradually increasing to a maintenance level.

Decoding Weight-Loss Wonders: How Mounjaro and Wegovy Are Changing the Obesity Landscape
0 Kudos
Comments
Displaying 0 of 0 comments ( View all | Add Comment )